Co-Diagnostics, Inc. announced that their CoPrimer platform was featured in presentations at the International Plant and Genome conference (PAG XXVII) last week in San Diego, California. The public introduction of a novel, one-step SNP genotyping methodology with scalable multiplex capability followed a joint development project over the past year to test the performance of CoPrimers in multiplexed reactions. It also coincided with a private label CoPrimer product launch by a global leader in the design and manufacture of sophisticated polymerase chain reaction (PCR) reagents and other custom oligonucleotide-based tools for applied markets. The patented structure of CoPrimers makes the platform ideal for a wide array of PCR applications, including infectious diseases, multiplexing of PCR reactions, SNP/SNV detection, agricultural and food supply chain uses, liquid biopsy, and next generation sequencing. Marketing for the private labeled product includes its ability to allow assay interchangeability, overcoming a common shortfall of traditional multiplex PCR technologies, and to enable multiplex PCR while maintaining workflow flexibility. This flexibility supports a much broader range of applications including gene expression, adventitious presence (AP) testing, copy number variation, and SNP differentiation. The product can be designed with a range of fluorescent dyes to fit most PCR detection instruments on the market and allows customers to generate twice as much data per reaction, which reduces overall cost of operations.